Kupffer cells are central in the removal of nanoparticles from the organism
Background
The study aims at revealing the fate of nanoparticles administered intravenously and intraperitoneally to adult female mice, some of which were pregnant. Gold nanoparticles were chosen as a model because these particles have been found to be chemically inert and at the same time are easily traced by autometallography (AMG) at both ultrastructural and light microscopic levels.
Results
Gold nanoparticles were injected intravenously (IV) or intraperitoneally (IP) and traced after 1, 4 or 24 hours. For IV injections 2 and 40 nm particles were used; for IP injections 40 nm particles only. The injected nanoparticles were found in macrophages only, and at moderate exposure primarily in the Kupffer cells in the liver. IV injections resulted in a rapid accumulation/clustering of nanoparticles in these liver macrophages, while the uptake in spleen macrophages was moderate. IP injections were followed by a delayed uptake in the liver and included a moderate uptake in macrophages located in mesenteric lymph nodes, spleen and small intestine. Ultrastructurally, the AMG silver enhanced nanocrystals were found in lysosome-like organelles of the Kupffer cells and other macrophages wherever located.
Accumulations of gold nanoparticles were not found in any other organs analysed, i.e. kidneys, brain, lungs, adrenals, ovaries, placenta, and fetal liver, and the control animals were all void of AMG staining.
Conclusion
Our results suggest that: (1) inert gold nanoparticles do not penetrate cell membranes by non-endocytotic mechanisms, but are rather taken up by endocytosis; (2) gold nanoparticles, independent of size, are taken up primarily by Kupffer cells in the liver and secondarily by macrophages in other places; (3) gold nanoparticles do not seem to penetrate the placenta barrier; (4) the blood-brain barrier seems to protect the central nervous system from gold nanoparticles; (5) 2 nanometer gold particles seem to be removed not only by endocytosis by macrophages, and we hypothesize that part of these tiny nanoparticles are released into the urine as a result of simple filtration in the renal glomeruli.
Top-30
Journals
|
2
4
6
8
10
12
14
16
18
|
|
|
ACS Nano
17 publications, 3.43%
|
|
|
Nanotoxicology
14 publications, 2.83%
|
|
|
Journal of Controlled Release
11 publications, 2.22%
|
|
|
Nanomedicine
10 publications, 2.02%
|
|
|
Particle and Fibre Toxicology
10 publications, 2.02%
|
|
|
International Journal of Molecular Sciences
9 publications, 1.82%
|
|
|
Nanomedicine: Nanotechnology, Biology, and Medicine
9 publications, 1.82%
|
|
|
Scientific Reports
8 publications, 1.62%
|
|
|
Nanoscale
7 publications, 1.41%
|
|
|
Pharmaceutics
6 publications, 1.21%
|
|
|
PLoS ONE
6 publications, 1.21%
|
|
|
Biomaterials
6 publications, 1.21%
|
|
|
Molecular Pharmaceutics
6 publications, 1.21%
|
|
|
Journal of Materials Chemistry B
6 publications, 1.21%
|
|
|
Nanomaterials
5 publications, 1.01%
|
|
|
Journal of Nanoparticle Research
5 publications, 1.01%
|
|
|
Journal of Drug Delivery Science and Technology
5 publications, 1.01%
|
|
|
Advanced Drug Delivery Reviews
5 publications, 1.01%
|
|
|
International Journal of Pharmaceutics
5 publications, 1.01%
|
|
|
Small
5 publications, 1.01%
|
|
|
Nano Letters
5 publications, 1.01%
|
|
|
Archives of Toxicology
4 publications, 0.81%
|
|
|
Journal of Nanobiotechnology
4 publications, 0.81%
|
|
|
Nature Communications
4 publications, 0.81%
|
|
|
Toxicology
4 publications, 0.81%
|
|
|
ACS Omega
4 publications, 0.81%
|
|
|
Toxicological Sciences
4 publications, 0.81%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
4 publications, 0.81%
|
|
|
Pharmaceutical Research
3 publications, 0.61%
|
|
|
2
4
6
8
10
12
14
16
18
|
Publishers
|
20
40
60
80
100
120
140
|
|
|
Elsevier
127 publications, 25.66%
|
|
|
Springer Nature
89 publications, 17.98%
|
|
|
American Chemical Society (ACS)
57 publications, 11.52%
|
|
|
Wiley
44 publications, 8.89%
|
|
|
Taylor & Francis
33 publications, 6.67%
|
|
|
MDPI
33 publications, 6.67%
|
|
|
Royal Society of Chemistry (RSC)
26 publications, 5.25%
|
|
|
Oxford University Press
7 publications, 1.41%
|
|
|
Public Library of Science (PLoS)
6 publications, 1.21%
|
|
|
Bentham Science Publishers Ltd.
5 publications, 1.01%
|
|
|
SAGE
5 publications, 1.01%
|
|
|
Frontiers Media S.A.
4 publications, 0.81%
|
|
|
Hindawi Limited
4 publications, 0.81%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
4 publications, 0.81%
|
|
|
Pleiades Publishing
3 publications, 0.61%
|
|
|
Beilstein-Institut
2 publications, 0.4%
|
|
|
F1000 Research
2 publications, 0.4%
|
|
|
IOP Publishing
2 publications, 0.4%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
2 publications, 0.4%
|
|
|
IGI Global
2 publications, 0.4%
|
|
|
The American Association of Immunologists
1 publication, 0.2%
|
|
|
ASME International
1 publication, 0.2%
|
|
|
Canadian Science Publishing
1 publication, 0.2%
|
|
|
Institution of Engineering and Technology (IET)
1 publication, 0.2%
|
|
|
Impact Journals
1 publication, 0.2%
|
|
|
Mary Ann Liebert
1 publication, 0.2%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.2%
|
|
|
World Scientific
1 publication, 0.2%
|
|
|
Shenyang Pharmaceutical University
1 publication, 0.2%
|
|
|
20
40
60
80
100
120
140
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.